Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clareon PanOptix Versus AcrySof PanOptix : Prospective Study Comparing Contrast Sensitivity
Sponsor: Assistance Publique - Hôpitaux de Paris
Summary
Retrospective, comparative, interventional, randomized, single-center study, contralateral (the patient's 2 eyes will be implanted: 1 CPO and the other APO) Patients presenting for cataract surgery with a request for presbyopia correction and managed as part of routine clinical practice. The main aim of the study is to demonstrate that contrast sensitivity is better with the Clareon PanOptix (CPO) intraocular lens (IOL) compared with the AcrySof PanOptix (APO) IOL 3 months after implantation.
Official title: Clareon PanOptix Versus AcrySof PanOptix : Prospective Study Comparing Contrast Sensitivity. Study of Two Different Material of Intra Ocular Multifocal Lenses Aiming to Compare the Effect on Contrast Sensitivity.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-10-01
Completion Date
2026-10-15
Last Updated
2026-03-30
Healthy Volunteers
No
Conditions
Interventions
Acrysof™ PanOptix™ toric or not, trifocal IOL CE marked, Alcon company.
both of the patient's eyes will be implanted: 1 CPO and the other APO
Clareon Panoptix
both of the patient's eyes will be implanted: 1 CPO and the other APO
Locations (1)
Assistance Publique - Hôpitaux de Paris, Ophtalomopôle - Hôpital COCHIN
Paris, Île-de-France Region, France